Imaging of myocardial perfusion with magnetic resonance

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 6, 2004, Pages 750-757

  Barkhausen, Jörg ^a   Hunold, Peter ^a   Jochims, Markus ^b   Debatin, Jörg F ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b ELISABETH KRANKENHAUS ESSEN   (Germany)

Author keywords

Contrast agents; Coronary artery disease; Magnetic resonance imaging; Myocardial perfusion; Pulse sequences

Indexed keywords

CONTRAST MEDIUM;

CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; FIRST PASS EFFECT; HEART MUSCLE PERFUSION; HUMAN; INDUSTRIALIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

CORONARY CIRCULATION; CORONARY DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 2942716902     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20073     Document Type: Review

References (51)

1. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987;59:23C-30C.
2. Hannoush H, Shaar K, Alam S, Nasrallah A, Sawaya J, Dakik HA. Analysis of referral patterns, predictive accuracy, and impact on patient management of myocardial perfusion imaging in a new nuclear cardiology laboratory. J Nucl Cardiol 2003;10:148-153.
3. Schwaiger M, Melin J. Cardiological applications of nuclear medicine. Lancet 1999;354:661-666.
4. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med 1994;35:693-698.
5. Muzik O, Duvernoy C, Beanlands RS, et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1998;31:534-540.
6. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79:825-835.
7. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57-62.
8. Mansoor MR, Heller GV. Recent developments in the prognostic use of myocardial perfusion imaging. Curr Opin Cardiol 1997;12:571-580.
9. Wagner A, Mahrholdt H, Holly TA, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379.
10. Ragosta M, Beller GA. The noninvasive assessment of myocardial viability. Clin Cardiol 1993;16:531-538.
11. Bourdarias JP. Coronary reserve: concept and physiological variations. Eur Heart J 1995;16(Suppl I):2-6.
12. Wilke N, Jerosch-Herold M, Wang Y, et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-384.
13. Iliceto S. Pharmacological agents for stress testing in the diagnosis of coronary artery disease. Eur Heart J 1995;16(Suppl M):1-2.
14. Bache RJ, Schwartz JS. Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation 1982;65:928-935.
15. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770.
16. Schaefer S, van Tyen R, Saloner D. Evaluation of myocardial perfusion abnormalities with gadolinium-enhanced snapshot MR imaging in humans. Work in progress. Radiology 1992;185:795-801.
17. van Rugge FP, Boreel JJ, van der Wall EE, et al. Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:959-965.
18. Slavin GS, Wolff SD, Gupta SN, Foo TK. First-pass myocardial perfusion MR imaging with interleaved notched saturation: feasibility study. Radiology 2001;219:258-263.
19. Nagele T, Miller S, Klose U, et al. Optimization of numerical measurement parameters for ECG-triggered MRI snapshot-FLASH myocardial perfusion studies. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;170:89-93. [Ger]
20. Bertschinger KM, Nanz D, Buechi M, et al. Magnetic resonance myocardial first-pass perfusion imaging: parameter optimization for signal response and cardiac coverage. J Magn Reson Imaging 2001;14:556-562.
21. Epstein FH, Arai AE. Optimization of fast cardiac imaging using an echo-train readout. J Magn Reson Imaging 2000;11:75-80.
22. Epstein FH, London JF, Peters DC, et al. Multislice first-pass cardiac perfusion MRI: validation in a model of myocardial infarction. Magn Reson Med 2002;47:482-491.
23. Sakuma H, Takeda K, Higgins CB. Fast magnetic resonance imaging of the heart. Eur J Radiol 1999;29:101-113.
24. Barkhausen J, Ruehm SG, Goyen M, Buck T, Laub G, Debatin JF. MR evaluation of ventricular function: true fast imaging with steady-state precession versus fast low-angle shot cine MR imaging: feasibility study. Radiology 2001;219:264-269.
25. Huang TY, Huang IJ, Chen CY, Scheffler K, Chung HW, Cheng HC. Are TrueFISP images T2/T1-weighted? Magn Reson Med 2002;48:684-688.
26. Schreiber WG, Schmitt M, Kalden P, Mohrs OK, Kreitner KF, Thelen M. Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP. J Magn Reson Imaging 2002;16:641-652.
27. Prince MR, Grist TM, Debatin JF. 3D contrast MR angiography. Berlin: Springer-Verlag; 2003.
28. Goyen M, Lauenstein TC, Herborn CU, Debatin JF, Bosk S, Ruehm SG. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 2001;14:602-607.
29. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993;30:337-346.
30. Tong CY, Prato FS, Wisenberg G, et al. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Magn Reson Med 1993;30:332-336.
31. Gerber BL, Bluemke DA, Chin BB, et al. Single-vessel coronary artery stenosis: myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine. Radiology 2002;225:104-112.
32. Wilke N, Simm C, Zhang J, et al. Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med 1993;29:485-497.
33. Neyran B, Janler MF, Casali C, Revel D, Canet Soulas EP. Mapping myocardial perfusion with an intravascular MR contrast agent: robustness of deconvolution methods at various blood flows. Magn Reson Med 2002;48:166-179.
34. Jerosch-Herold M, Wilke N, Wang Y, et al. Direct comparison of an intravascular and an extracellular contrast agent for quantification of myocardial perfusion. Cardiac MRI Group. Int J Card Imaging 1999;15:453-464.
35. Canet Soulas EP, Marchand B, Casali C, Corot C, Douek P, Revel D. Evaluation of MR contrast agents with high relaxivity and reduced interstitial diffusion for contrast material-enhanced MRA and myocardial perfusion studies. Acad Radiol 2002;9(Suppl 1):S88-891.
36. Bluemke DA, Kraitchman DL, Heldman A, Chin BB, Steinert C. Optimal characterization of myocardial perfusion with Angio-MARK. Acad Radiol 2002;9(Suppl 1):S78.
37. Wilke N, Kroll K, Merkle H, et al. Regional myocardial blood volume and flow: first-pass MR imaging with polylysine-Gd-DTPA. J Magn Reson Imaging 1995;5:227-237.
38. Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
39. Schwitter J, Nanz D, Kneifel S, et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235.
40. al-Saadi N, Gross M, Paetsch I, et al. Dobutamine induced myocardial perfusion reserve index with cardiovascular MR in patients with coronary artery disease. J Cardiovasc Magn Reson 2002;4:471-480.
41. Sensky PR, Samani NJ, Reek C, Cherryman GR. Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach. Int J Cardiovasc Imaging 2002;18:373-383; discussion, 385-376.
42. Nagel E, al-Saadi N, Fleck E. Cardiovascular magnetic resonance: myocardial perfusion. Herz 2000;25:409-416.
43. Arai AE. Magnetic resonance first-pass myocardial perfusion imaging. Top Magn Reson Imaging 2000;11:383-398.
44. Kraitchman DL, Wilke N, Hexeberg E, et al. Myocardial perfusion and function in dogs with moderate coronary stenosis. Magn Reson Med 1996;35:771-780.
45. Schmitt M, Mohrs OK, Petersen SE, et al. Evaluation of myocardial perfusion reserve in patients with CAD using contrast-enhanced MRI: a comparison between semiquantitative and quantitative methods. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 2002;174:187-195. [Ger]
46. al-Saadi N, Gross M, Bornstedt A, et al. Comparison of various parameters for determining an index of myocardial perfusion reserve in detecting coronary stenosis with cardiovascular magnetic resonance tomography. Z Kardiol 2001;90:824-834. [Ger]
47. Lauerma K, Virtanen KS, Sipila LM, Hekali P, Aronen HJ. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. Circulation 1997;96:2859-2867.
48. Matheijssen NA, Louwerenburg HW, van Rugge FP, et al. Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med 1996;35:221-228.
49. Cullen JH, Horsfield MA, Reek CR, Cherryman GR, Barnett DB, Samani NJ. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999;33:1386-1394.
50. Wilke NM, Jerosch-Herold M, Zenovich A, Stillman AE. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging 1999;10:676-685.
51. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.